Research ArticleCancer

Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy

See allHide authors and affiliations

Science Translational Medicine  12 Aug 2020:
Vol. 12, Issue 556, eaaz6606
DOI: 10.1126/scitranslmed.aaz6606

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article